BIIB

Biogen Idec Inc. News Headlines

$324.39
*  
12.98
4.17%
Get BIIB Alerts
*Delayed - data as of Oct. 21, 2014 15:46 ET  -  Find a broker to begin trading BIIB now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    BIIB After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Determining Biogen's Fair Value
10/21/2014 4:08:00 AM - Seeking Alpha


Will Biogen Idec (BIIB) Pull a Surprise this Earnings Season? - Analyst Blog
10/20/2014 4:45:00 PM - Zacks.com


Will Sangamo (SGMO) Incur Wider-than-Expected Q3 Loss? - Analyst Blog
10/20/2014 12:50:00 PM - Zacks.com


Forward Pharma's Threat To Biogen Idec's Tecfidera
10/20/2014 11:12:00 AM - Seeking Alpha


Genervon ALS drug shows encouraging results
10/20/2014 8:27:00 AM - Seeking Alpha


This Drug Could Outsell Medical Marijuana
10/19/2014 12:02:02 PM - Motley Fool


Baxter International: A Post-Earnings Buy As A Spin-Off Approaches
10/19/2014 7:08:00 AM - Seeking Alpha


MARKET SNAPSHOT: More Than 1/3 of Dow Stocks To Report This Week
10/19/2014 5:31:00 AM - Dow Jones Business News


US IPO Weekly Recap: 5 IPOs achieve moderate gains during the market slide and a biotech rejection
10/17/2014 8:55:33 PM - Renaissance Capital


Sustainability Pays: 3 Green Companies Making Money
10/16/2014 11:00:02 AM - Motley Fool


Forward Pharma goes backward: year's largest biotech drops 17% on IPO
10/15/2014 9:11:40 PM - Renaissance Capital


Isis Pharmaceuticals Unveils Mid-Stage Data on ISIS-SMNRx - Analyst Blog
10/13/2014 5:50:00 PM - Zacks.com


3 Fairly-Valued Companies Worthy Of Further Research This Week
10/13/2014 8:59:00 AM - Seeking Alpha


1 Huge Risk Facing This Marijuana Stock
10/12/2014 12:02:02 PM - Motley Fool


Griffin Securities' Keith Markey On The Promise Of RNAi And Synthetic Biologics
10/10/2014 8:54:00 AM - Seeking Alpha


Notable Two Hundred Day Moving Average Cross - BIIB
10/8/2014 11:52:25 AM - BNK Invest


XLV, AMGN, BMY, BIIB: ETF Inflow Alert
10/7/2014 10:55:07 AM - BNK Invest


Biogen Idec Destroys Ecolab In 5 Games Of The Wild Card Round
10/6/2014 10:52:00 AM - Seeking Alpha


5 States Expected to See the Biggest Increase in Alzheimer's Disease
10/5/2014 11:07:02 AM - Motley Fool


The Next Blue-Chip Stocks: Biogen Idec
10/4/2014 11:32:02 AM - Motley Fool


Individual Investor Portfolio: Major Sectors Are Beginning To Move In Opposing Directions
10/4/2014 3:39:00 AM - Seeking Alpha


Perrigo Sells Some Assets to Imago Pharmaceuticals - Analyst Blog
10/3/2014 4:45:00 PM - Zacks.com


Growth Portfolio World Series
10/3/2014 2:03:00 AM - Seeking Alpha


These Companies Are Saving Money and Sticking You With a Tax Bill
9/27/2014 8:00:03 AM - Motley Fool


ETF Outlook: S&P Health Care Select SPDR ETF (XLV)
9/25/2014 12:31:27 PM - Marc Chaikin